INmune Bio Inc. (INMB)
undefined
undefined%
At close: undefined
4.75
-0.46%
After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Revenue 155.00K 374.00K 181.00K 10.92K 77.69M - - - -
Cost of Revenue - - - - - - - - -
Gross Profit 155.00K 374.00K 181.00K 10.92K 77.69M - - - -
Operating Income -29.74M -25.95M -29.15M -12.23M -7.76M -12.44M -981.48K -227.49K -48.87K
Interest Income - - - - 77.69K - - - -
Pretax Income -30.01M -27.30M -30.34M -12.10M -7.68M -12.44M -831.49K -277.49K -48.87K
Net Income -30.01M -28.65M -30.34M -12.10M -9.14M -12.44M -831.49K -277.49K -48.87K
Selling & General & Admin 9.62M 9.26M 8.79M 6.32M 6.02M 11.33M 546.12K 126.00K 48.87K
Research & Development 20.27M 17.07M 20.54M 5.92M 3.28M 1.11M 435.36K 101.50K -
Other Expenses - -1.35M -1.19M 128.52K - - -6 - -
Operating Expenses 29.90M 26.32M 29.33M 12.24M 9.30M 12.44M 981.48K 227.49K 48.87K
Interest Expense - 1.35M - - - - - - -
Selling & Marketing Expenses - - - - - - - - -146.60K
Cost & Expenses 29.90M 26.32M 29.33M 12.24M 9.30M 12.44M 981.48K 227.49K 48.87K
Income Tax - 1.35M -29.15M -12.23M 1.46M -161.14K -1.13M -177.49K -
Shares Outstanding (Basic) 17.98M 17.93M 16.13M 11.99M 10.27M 11.22M 11.22M 11.22M 11.22M
Shares Outstanding (Diluted) 17.98M 17.93M 16.13M 11.99M 10.27M 11.22M 11.22M 11.22M 11.22M
EPS (Basic) -1.67 -1.6 -1.88 -1.01 -0.89 -1.11 -0.07 -0.02 -0.00
EPS (Diluted) -1.67 -1.6 -1.88 -1.01 -0.89 -1.11 -0.07 -0.02 -0.00
EBITDA - - - - - - 149.99K -50.00K 146.60K
Depreciation & Amortization 29.74M 25.95M 29.15M 12.23M 9.30M 12.44M 981.48K 227.49K 195.47K